Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Tnelda Zunie"'
Autor:
Laura J Edwards, Ashley L Fowlkes, Meredith G Wesley, Jennifer L Kuntz, Marilyn J Odean, Alberto J Caban-Martinez, Kayan Dunnigan, Andrew L Phillips, Lauren Grant, Meghan K Herring, Holly C Groom, Karley Respet, Shawn Beitel, Tnelda Zunie, Kurt T Hegmann, Archana Kumar, Gregory Joseph, Brandon Poe, Paola Louzado-Feliciano, Michael E Smith, Matthew S Thiese, Natasha Schaefer-Solle, Young M Yoo, Carlos A Silvera, Julie Mayo Lamberte, Josephine Mak, L Clifford McDonald, Matthew J Stuckey, Preeta Kutty, Melissa L Arvay, Sarang K Yoon, Harmony L Tyner, Jefferey L Burgess, Danielle Rentz Hunt, Jennifer Meece, Manjusha Gaglani, Allison L Naleway, Mark G Thompson
Publikováno v:
JMIR Research Protocols, Vol 10, Iss 12, p e31574 (2021)
BackgroundWorkers critical to emergency response and continuity of essential services during the COVID-19 pandemic are at a disproportionally high risk of SARS-CoV-2 infection. Prospective cohort studies are needed for enhancing the understanding of
Externí odkaz:
https://doaj.org/article/ad4bf3ac76364f96960e1b896130b36c
Autor:
Allison L Naleway, Sara S Kim, Brendan Flannery, Min Z Levine, Kempapura Murthy, Suryaprakash Sambhara, Shivaprakash Gangappa, Laura J Edwards, Sarah Ball, Lauren Grant, Tnelda Zunie, Weiping Cao, F Liaini Gross, Holly Groom, Alicia M Fry, Danielle Hunt, Zuha Jeddy, Margarita Mishina, Meredith G Wesley, Sarah Spencer, Mark G Thompson, Manjusha Gaglani, Fatimah S Dawood
Publikováno v:
Open Forum Infectious Diseases.
Background Emerging data suggest second-generation influenza vaccines with higher hemagglutinin (HA) antigen content and/or different production methods may induce stronger antibody responses to HA than standard-dose egg-based influenza vaccines in a
Autor:
Manjusha Gaglani, Sara S Kim, Allison L Naleway, Min Z Levine, Laura Edwards, Kempapura Murthy, Kayan Dunnigan, Tnelda Zunie, Holly Groom, Sarah Ball, Zuha Jeddy, Danielle Hunt, Meredith G Wesley, Suryaprakash Sambhara, Shivaprakash Gangappa, Lauren Grant, Weiping Cao, F Liaini Gross, Margarita Mishina, Alicia M Fry, Mark G Thompson, Fatimah S Dawood, Brendan Flannery
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
Background Antibody responses to non–egg-based standard-dose cell-culture influenza vaccine (containing 15 µg hemagglutinin [HA]/component) and recombinant vaccine (containing 45 µg HA/component) during consecutive seasons have not been studied i
Autor:
Fernanda P. Silveira, Amelia Drennan, Rebecca Kondor, Manjusha Gaglani, Shoshona Le, Richard K. Zimmerman, Briana Krantz, Kailey Hughes, Adam S. Lauring, Bethany Alicie, Yuwei Zhu, Arnold S. Monto, Arundhati Rao, Manish M. Patel, K G Balasubramani, Joshua G. Petrie, Heath White, Christopher Trabue, Manohar Mutnal, Donald B Middleton, Nicole Wheeler, Mark W Tenforde, Karen Speer, Lisa M Keong, Thomas J. Stark, Sean G Saul, Lori Stiefel, Kevin Chang, Jill M. Ferdinands, Ryan E. Malosh, Mohamed Yassin, Shekhar Ghamande, Emily T. Martin, Chandni Raiyani, Rendi McHenry, Natasha B. Halasa, Jan Orga, Kelsey Bounds, Tresa McNeal, John W Williams, Donna Carillo, Lydia Clipper, Lois Lamerato, Heather Eng, Alejandro Arroliga, Mary Patricia Nowalk, H. Keipp Talbot, Claudia Guevara Pulido, Dayna Wyatt, Emily Sedillo, Alina Simion, Tnelda Zunie, Zhouwen Liu, Kempapura Murthy, Laura Adams, Stephanie Longmire, John Barnes, Juliana Almeida da Silva, Anurag Malani, Kellie Graves, Samantha M Olson, Lynn Peterson
Publikováno v:
J Infect Dis
Background Influenza causes significant morbidity and mortality and stresses hospital resources during periods of increased circulation. We evaluated the effectiveness of the 2019–2020 influenza vaccine against influenza-associated hospitalization
Autor:
Manohar Mutnal, Arundhati Rao, Yuwei Zhu, Lisa M Keong, Laura Adams, Juliana DaSilva, Lydia Clipper, Kempapura Murthy, Kailey Hughes, John W Williams, Briana Krantz, Claudia Guevara Pulido, Mary Patricia Nowalk, Emily R Smith, Jill M. Ferdinands, Thomas J. Stark, Joshua G. Petrie, Rendi McHenry, Karen Speer, Manish M. Patel, Natasha B. Halasa, Helen Talbot, Ryan E. Malosh, Shekhar Ghamande, Emily T. Martin, Sean G Saul, Lori Stiefel, Lynn Peterson, Kelsey Bounds, Chandni Raiyani, Alejandro Arroliga, Donna Carillo, Kevin Chang, Goundappa K. Balasubramani, Stephanie Longmire, Kellie Graves, Donald B Middleton, Heather Eng, Dayna Wyatt, Tnelda Zunie, Emily Sedillo, Jan Orga, Alina Simion, Mohamed Yassin, Zhouwen Liu, Anurag Malani, Shoshona Le, Arnold S. Monto, Richard K. Zimmerman, Adam S. Lauring, Fernanda P. Silveira, Heath White, Nicole Wheeler, Lois Lamerato, Bethany Alicie, Amelia Drennan, Manjusha Gaglani
Publikováno v:
J Infect Dis
We estimated vaccine effectiveness (VE) for prevention of influenza-associated hospitalizations among adults during the 2018–2019 influenza season. Adults admitted with acute respiratory illness to 14 hospitals of the US Hospitalized Adult Influenz
Autor:
Michael E. Smith, Harmony L. Tyner, Karley Respet, L. Clifford McDonald, Alberto J. Caban-Martinez, Sarang K Yoon, Kayan Dunnigan, Meghan K Herring, Laura J. Edwards, Brandon Poe, Holly C Groom, Jefferey L. Burgess, Shawn C. Beitel, Matthew S. Thiese, Andrew L Phillips, Gregory Joseph, Lauren Grant, Preeta K. Kutty, Jennifer L. Kuntz, Natasha Schaefer-Solle, Young M Yoo, Melissa L. Arvay, Matthew J. Stuckey, Danielle R. Hunt, Mark G. Thompson, Josephine Mak, Kurt T. Hegmann, Archana Kumar, Marilyn J. Odean, Tnelda Zunie, Meredith G Wesley, Paola Louzado-Feliciano, Julie Mayo Lamberte, Manjusha Gaglani, Allison L. Naleway, Jennifer K. Meece, Carlos A. Silvera, Ashley Fowlkes
Publikováno v:
JMIR Research Protocols
Background Workers critical to emergency response and continuity of essential services during the COVID-19 pandemic are at a disproportionally high risk of SARS-CoV-2 infection. Prospective cohort studies are needed for enhancing the understanding of
Autor:
Laura J Edwards, Ashley L Fowlkes, Meredith G Wesley, Jennifer L Kuntz, Marilyn J Odean, Alberto J Caban-Martinez, Kayan Dunnigan, Andrew L Phillips, Lauren Grant, Meghan K Herring, Holly C Groom, Karley Respet, Shawn Beitel, Tnelda Zunie, Kurt T Hegmann, Archana Kumar, Gregory Joseph, Brandon Poe, Paola Louzado-Feliciano, Michael E Smith, Matthew S Thiese, Natasha Schaefer-Solle, Young M Yoo, Carlos A Silvera, Julie Mayo Lamberte, Josephine Mak, L Clifford McDonald, Matthew J Stuckey, Preeta Kutty, Melissa L Arvay, Sarang K Yoon, Harmony L Tyner, Jefferey L Burgess, Danielle Rentz Hunt, Jennifer Meece, Manjusha Gaglani, Allison L Naleway, Mark G Thompson
BACKGROUND Workers critical to emergency response and continuity of essential services during the COVID-19 pandemic are at a disproportionally high risk of SARS-CoV-2 infection. Prospective cohort studies are needed for enhancing the understanding of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9f2065b73bcd88f8dd8678227460bac7
https://doi.org/10.2196/preprints.31574
https://doi.org/10.2196/preprints.31574
Autor:
Anna Kelleher, Karen Lutrick, Yan Li, Young M Yoo, Jefferey L. Burgess, Danielle R Hunt, Sarang K Yoon, Matthew S. Thiese, Alberto J. Caban-Martinez, Katherine Ellingson, Erik Reisdorf, Allison L. Naleway, Harmony L. Tyner, Mark G. Thompson, Erika Hanson, Lauren Grant, Michael E. Smith, Jennifer K. Meece, John R. Barnes, Joe K. Gerald, Xiaxiao Sun, Kyley Guenther, Meredith G Wesley, Tnelda Zunie, Manjusha Gaglani, Lynn Ivacic, Josephine Mak, Shawn C. Beitel, Lauren E.W. Olsho, Alicia M. Fry, Kimberly Groover, Jing Zhang, Jennifer L. Kuntz, Patrick Rivers, Marilyn J Odean, Andrew L Phillips, Suxiang Tong, Elisha Stefanski, Natasha Schaefer-Solle, Gregory Joseph, Laura J. Edwards, Rachel T Brown, Holly C Groom, Ashley Fowlkes, Tyler C Morrill, Preeta K. Kutty, Eduardo Azziz-Baumgartner, Allen C. Bateman, Brian Lynch, Julie Mayo Lamberte, Meghan K Herring, Melissa L Arvay, Kayan Dunnigan, Monica E. Dickerson, Ying Tao Zhou, Brandon P Poe, Kurt T. Hegmann
BACKGROUNDInformation is limited on messenger RNA (mRNA) BNT162b2 (Pfizer-BioNTech) and mRNA-1273 (Moderna) COVID-19 vaccine effectiveness (VE) in preventing SARS-CoV-2 infection or attenuating disease when administered in real-world conditions.METHO
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6f7b11f024384740faab8a332452156c
https://doi.org/10.1101/2021.06.01.21257987
https://doi.org/10.1101/2021.06.01.21257987
Autor:
Preeta K. Kutty, Matthew S. Thiese, Melissa L Arvay, Yan Li, Young M Yoo, Lauren Grant, Tyler C Morrill, Shawn C. Beitel, Kayan Dunnigan, Anna Kelleher, Elisha Stefanski, Brian Lynch, Monica E. Dickerson, Katherine Ellingson, Allison L. Naleway, Laura J. Edwards, Kimberly Groover, Patrick Rivers, Julie Mayo Lamberte, Rachel T Brown, Meghan K Herring, Yingtao Zhou, Karen Lutrick, Harmony L. Tyner, Alberto J. Caban-Martinez, John R. Barnes, Erik Reisdorf, Holly C Groom, Brandon P Poe, Kurt T. Hegmann, Manjusha Gaglani, Jennifer K. Meece, Allen C. Bateman, Meredith G Wesley, Mark G. Thompson, Xiaoxiao Sun, Joseph Gerald, Marilyn J Odean, Suxiang Tong, Kyley Guenther, Danielle R Hunt, Sarang K Yoon, Eduardo Azziz-Baumgartner, Michael E. Smith, Lynn Ivacic, Jefferey L. Burgess, Jing Zhang, Jennifer L. Kuntz, Ashley L Fowlkes, Gregory Joseph, Alicia M. Fry, Josephine Mak, Lauren E.W. Olsho, Andrew L Phillips, Erika Hanson, Tnelda Zunie, Natasha Schaefer-Solle
Publikováno v:
The New England Journal of Medicine
Background Information is limited regarding the effectiveness of the two-dose messenger RNA (mRNA) vaccines BNT162b2 (Pfizer–BioNTech) and mRNA-1273 (Moderna) in preventing infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
Autor:
Mark W, Tenforde, Samantha M, Olson, Wesley H, Self, H Keipp, Talbot, Christopher J, Lindsell, Jay S, Steingrub, Nathan I, Shapiro, Adit A, Ginde, David J, Douin, Matthew E, Prekker, Samuel M, Brown, Ithan D, Peltan, Michelle N, Gong, Amira, Mohamed, Akram, Khan, Matthew C, Exline, D Clark, Files, Kevin W, Gibbs, William B, Stubblefield, Jonathan D, Casey, Todd W, Rice, Carlos G, Grijalva, David N, Hager, Arber, Shehu, Nida, Qadir, Steven Y, Chang, Jennifer G, Wilson, Manjusha, Gaglani, Kempapura, Murthy, Nicole, Calhoun, Arnold S, Monto, Emily T, Martin, Anurag, Malani, Richard K, Zimmerman, Fernanda P, Silveira, Donald B, Middleton, Yuwei, Zhu, Dayna, Wyatt, Meagan, Stephenson, Adrienne, Baughman, Kelsey N, Womack, Kimberly W, Hart, Miwako, Kobayashi, Jennifer R, Verani, Manish M, Patel, Tnelda, Zunie
Publikováno v:
MMWR. Morbidity and mortality weekly report. 70(18)
Adults aged ≥65 years are at increased risk for severe outcomes from COVID-19 and were identified as a priority group to receive the first COVID-19 vaccines approved for use under an Emergency Use Authorization (EUA) in the United States (1-3). In